Wolverine Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,880
| Closed | -$918K | – | 2719 |
|
|
2021
Q4 | $918K | Buy |
+9,880
| New | +$651K | 0.01% | 824 |
|
|
2021
Q3 | – | Sell |
-1,823
| Closed | -$124K | – | 2652 |
|
|
2021
Q2 | $124K | Buy |
1,823
+1,608
| +748% | +$105K | ﹤0.01% | 1412 |
|
|
2021
Q1 | $14K | Buy |
215
+195
| +975% | +$15K | ﹤0.01% | 1833 |
|
|
2020
Q4 | $1K | Buy |
+20
| New | +$1.5K | ﹤0.01% | 1609 |
|
|
2016
Q3 | – | Sell |
-100
| Closed | -$1K | – | 1387 |
|
|
2016
Q2 | $1K | Buy |
100
+80
| +400% | +$1.43K | ﹤0.01% | 1183 |
|
|
2016
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 1714 |
|
|
2015
Q4 | $0 | Buy |
+20
| New | +$408 | ﹤0.01% | 1998 |
|
|
2014
Q4 | – | Sell |
-7,950
| Closed | -$333K | – | 2583 |
|
|
2014
Q3 | $333K | Buy |
+7,950
| New | +$355K | 0.01% | 846 |
|
|
2014
Q1 | – | Sell |
-7,920
| Closed | -$463K | – | 2871 |
|
|
2013
Q4 | $463K | Buy |
7,920
+6,800
| +607% | +$355K | 0.01% | 804 |
|
|
2013
Q3 | $59K | Buy |
1,120
+850
| +315% | +$57.1K | ﹤0.01% | 1666 |
|
|
2013
Q2 | $20K | Buy |
+270
| New | +$22K | ﹤0.01% | 2013 |
|
Wolverine Asset Management's ARNA Position: Q1 2022 in Review
Wolverine Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,880 shares — an estimated $918K sold.
Wolverine Asset Management first reported a position in ARNA in Q2 2013 and held it in 11 quarters. The position peaked at $918K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Wolverine Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Wolverine Asset Management sold 9,880 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $918K.
- Wolverine Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
- Wolverine Asset Management's Arena Pharmaceuticals Inc position peaked at $918K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Wolverine Asset Management's 13F filing for Q1 2022, filed 4 May 2022.